This would suggest that our high frequency MB mouse model Ptch1+/−/Tis21KO, carrying activation of both the Shh and the PI3K/AKT/mTOR pathways, could be a model representative of such a cohort of patients with high-risk Shh-type medulloblastoma. This evidence concerns the gene MTOR and medulloblastoma.